The Fallopian Tube: Primary Site of Most Pelvic High-grade Serous Carcinomas
暂无分享,去创建一个
D. Huntsman | M. Köbel | Dianne Miller | B. Gilks | B. Rosen | S. Salvador | D. Miller
[1] F. Gaytán,et al. Macrophages in human fallopian tube and ovarian epithelial inclusion cysts. , 2007, Journal of reproductive immunology.
[2] R. Berkowitz,et al. Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship , 2007, The American journal of surgical pathology.
[3] R. Drapkin,et al. The distal fallopian tube: a new model for pelvic serous carcinogenesis , 2007, Current opinion in obstetrics & gynecology.
[4] J. Garber,et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube , 2007 .
[5] P. Radice,et al. Incidental Carcinomas in Prophylactic Specimens in BRCA1 and BRCA2 Germ-line Mutation Carriers, With Emphasis on Fallopian Tube Lesions: Report of 6 Cases and Review of the Literature , 2006, The American journal of surgical pathology.
[6] P. Kyyrönen,et al. Incidence of ovarian cancer of grand multiparous women--a population-based study in Finland. , 2006, Gynecologic oncology.
[7] H. Chiu,et al. Age at first birth, parity, and risk of death from ovarian cancer in Taiwan: a country of low incidence of ovarian cancer , 2006, International Journal of Gynecologic Cancer.
[8] Christopher P Crum,et al. The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer Syndrome , 2006, The American journal of surgical pathology.
[9] S. Gayther,et al. Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention , 2006, Acta obstetricia et gynecologica Scandinavica.
[10] T. Colgan,et al. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. , 2006, Gynecologic oncology.
[11] B. Karlan,et al. BRCA-Mutation–Associated Fallopian Tube Carcinoma: A Distinct Clinical Phenotype? , 2005, Obstetrics and gynecology.
[12] I. Shih,et al. Serous borderline tumours of the ovary , 2005, Histopathology.
[13] C. la Vecchia,et al. Breastfeeding and the risk of epithelial ovarian cancer in an Italian population. , 2005, Gynecologic oncology.
[14] S. Bonovas,et al. Do nonsteroidal anti-inflammatory drugs affect the risk of developing ovarian cancer? A meta-analysis. , 2005, British journal of clinical pharmacology.
[15] P. Vercellini,et al. Noncontraceptive health benefits of combined oral contraception. , 2005, Human reproduction update.
[16] T. Moss,et al. Failure of in vitro fertilization and embryo replacement following infection withChlamydia trachomatis , 1985, Journal of in Vitro Fertilization and Embryo Transfer.
[17] Blossom Damania,et al. Infectious agents and cancer: criteria for a causal relation. , 2004, Seminars in cancer biology.
[18] M. Goodman,et al. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. , 2004, American journal of obstetrics and gynecology.
[19] L. Brinton,et al. Ovarian cancer risk associated with varying causes of infertility. , 2004, Fertility and sterility.
[20] M. Pike,et al. Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study. , 2004, Fertility and sterility.
[21] A. Strandell,et al. The Presence of Cytokines and Growth Factors in Hydrosalpingeal Fluid , 2004, Journal of Assisted Reproduction and Genetics.
[22] J. Olsen,et al. Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65 000 sterilized women. , 2004, International journal of epidemiology.
[23] J. Schlesselman,et al. Safety concerns and health benefits associated with oral contraception. , 2004, American journal of obstetrics and gynecology.
[24] Michael T Deavers,et al. Grading Ovarian Serous Carcinoma Using a Two-Tier System , 2004, The American journal of surgical pathology.
[25] M. J. van de Vijver,et al. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up , 2004, British Journal of Cancer.
[26] C. la Vecchia,et al. Risk factors for different histological types of ovarian cancer , 2003, International Journal of Gynecologic Cancer.
[27] Miguel Rios,et al. Expression of Proinflammatory Cytokines and Receptors by Human Fallopian Tubes in Organ Culture following Challenge with Neisseria gonorrhoeae , 2003, Infection and Immunity.
[28] V. Beral,et al. Long‐term effects of oral contraceptives on ovarian cancer risk , 2002, International journal of cancer.
[29] N. Gupta,et al. Malignant gonadal mesothelioma , 2002, Current treatment options in oncology.
[30] Rochelle L. Garcia,et al. Pathologic findings in prophylactic oophorectomy specimens in high-risk women. , 2002, Gynecologic oncology.
[31] P. Dickman,et al. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study. , 2002, American journal of epidemiology.
[32] M. Sherman,et al. Salpingitis, Salpingoliths, and Serous Tumors of the Ovaries: Is There a Connection? , 2002, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[33] M. Goodman,et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. , 2002, American journal of epidemiology.
[34] P. V. van Diest,et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer , 2001, The Journal of pathology.
[35] A. Gjorgov. Tubal ligation and risk of ovarian cancer , 2001, The Lancet.
[36] C. Isaacs,et al. Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study , 2001, The Lancet.
[37] R. Demopoulos,et al. Clues to the Pathogenesis of Fallopian Tube Carcinoma: A Morphological and Immunohistochemical Case Control Study , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[38] P. Leung,et al. Ovarian surface epithelium: biology, endocrinology, and pathology. , 2001, Endocrine reviews.
[39] H. Ngan,et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. , 2000, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[40] M. Morgan,et al. Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. , 2000, Epidemiology.
[41] J. Williams. Noncontraceptive benefits of oral contraceptive use: an evidence-based approach. , 2000, International journal of fertility and women's medicine.
[42] N. Weiss,et al. Reproductive risk factors for mucinous and non-mucinous epithelial ovarian cancer. , 1999, Epidemiology.
[43] R. Ness,et al. Possible role of ovarian epithelial inflammation in ovarian cancer. , 1999, Journal of the National Cancer Institute.
[44] Z. A. McGee,et al. Gonococcal infection of human fallopian tube mucosa in organ culture: relationship of mucosal tissue TNF-alpha concentration to sloughing of ciliated cells. , 1999, Sexually transmitted diseases.
[45] A. Loercher,et al. The role of cytokines in both the normal and malignant ovary. , 1999, Endocrine-related cancer.
[46] A. Kaunitz. Oral contraceptive health benefits: perception versus reality. , 1999, Contraception.
[47] C. la Vecchia,et al. Treatment for infertility and risk of invasive epithelial ovarian cancer. , 1997, Human Reproduction.
[48] M. Cotterchio,et al. Surgical procedures associated with risk of ovarian cancer. , 1997, International journal of epidemiology.
[49] M. Quinn,et al. Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer , 1997, International journal of cancer.
[50] S. Kjaer,et al. Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. , 1997, Fertility and sterility.
[51] M. Thun,et al. Tubal ligation and fatal ovarian cancer in a large prospective cohort study. , 1997, American journal of epidemiology.
[52] K. Holmes,et al. Acute Pelvic Inflammatory Disease: Associations of Clinical and Laboratory Findings With Laparoscopic Findings , 1997, Obstetrics and gynecology.
[53] T. Cornelison,et al. Tubal ligation and the risk of ovarian carcinoma. , 1997, Cancer detection and prevention.
[54] D. Thomas,et al. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[55] G. Gorini,et al. The impact of oral contraception on chlamydial infection among patients with pelvic inflammatory disease. , 1996, Contraception.
[56] P. Clement,et al. Malignant mesotheliomas presenting as ovarian masses. A report of nine cases, including two primary ovarian mesotheliomas. , 1996, The American journal of surgical pathology.
[57] C. la Vecchia,et al. Pelvic inflammatory disease and risk of ovarian cancer. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[58] A. Junod,et al. Role of oxygen free radicals in cancer development. , 1996, European journal of cancer.
[59] H. Risch,et al. Pelvic inflammatory disease and the risk of epithelial ovarian cancer. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[60] W C Willett,et al. The causes and prevention of cancer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[61] H. Adami,et al. Parity, age at first childbirth, and risk of ovarian cancer , 1994, The Lancet.
[62] H. Risch,et al. Parity, contraception, infertility, and the risk of epithelial ovarian cancer. , 1994, American journal of epidemiology.
[63] C. Wahlberg. Tubal ligation, hysterectomy, and risk of ovarian cancer. , 1994, JAMA.
[64] W. Willett,et al. Tubal Ligation, Hysterectomy, and Risk of Ovarian Cancer: A Prospective Study , 1993 .
[65] J. Grudzinskas,et al. What is the true incidence of primary fallopian tube carcinoma? , 1993, International Journal of Gynecologic Cancer.
[66] K. Mittal. Morphologic precursors of ovarian epithelial tumors. , 1993, Obstetrics and gynecology.
[67] C. Johannes,et al. Re: "Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women". , 1993, American journal of epidemiology.
[68] A. Zeleniuch‐Jacquotte,et al. Contralateral Ovary in Unilateral Ovarian Carcinoma: A Search for Preneoplastic Lesions , 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[69] A. Whittemore,et al. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.
[70] B. Rosner,et al. A quantitative assessment of oral contraceptive use and risk of ovarian cancer , 1992, Obstetrics and gynecology.
[71] X. Bilian,et al. Hormonal profile of the menstrual cycle in Chinese women after tubal sterilization. , 1992 .
[72] B. Xiao,et al. Hormonal profile of the menstrual cycle in Chinese women after tubal sterilization. , 1992, Contraception.
[73] K. Teisala,et al. Serologic Evidence for the Role of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis in the Etiology of Tubal Factor Infertility and Ectopic Pregnancy , 1990, Sexually transmitted diseases.
[74] A. K. Bhattacharyya,et al. Structural changes in human cervical mucus. , 1989, The Indian journal of medical research.
[75] J. Pastorek,et al. Pelvic Inflammatory Disease During Pregnancy , 1987, Southern medical journal.
[76] D. Cramer,et al. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. , 1983, Journal of the National Cancer Institute.
[77] D. Cramer,et al. Determinants of ovarian cancer risk. I. Reproductive experiences and family history. , 1983, Journal of the National Cancer Institute.
[78] P. Layde,et al. Oral contraceptives and pelvic inflammatory disease. , 1982, American journal of obstetrics and gynecology.
[79] D. Cramer,et al. Ovarian cancer and talc. A case‐control study , 1982, Cancer.
[80] B. Ljung,et al. Contractile patterns of isolated oviductal smooth muscle under different hormonal conditions. , 1980, Fertility and sterility.
[81] I. Brosens,et al. Fimbrial microbiopsy. , 1976, The Journal of reproductive medicine.
[82] M F Fathalla,et al. Incessant ovulation--a factor in ovarian neoplasia? , 1971, Lancet.
[83] A. Hertig,et al. Primary carcinoma of the fallopian tube. , 1950, American journal of obstetrics and gynecology.
[84] E. Block. Primary Carcinoma of the Fallopian Tube , 1947, Acta radiologica.
[85] A. F. Brown,et al. Carcinoma of the Fallopian Tube. , 1942, California and western medicine.